Cargando…
Impacts of CYP2C19 Polymorphism and Clopidogrel Dosing on in-Stent Restenosis: A Retrospective Cohort Study in Chinese Patients
OBJECTIVE: This retrospective cohort study is to analyze the impacts of CYP2C19 polymorphism and clopidogrel dosing on in-stent restenosis (ISR) after coronary stenting. METHODS: Totally, 111 patients were included, who underwent percutaneous coronary intervention (PCI) with drug-eluting stent. Pati...
Autores principales: | Zhang, Min, Wang, Jiangrong, Zhang, Yong, Zhang, Pei, Jia, Zhisheng, Ren, Manyi, Jia, Xiaomeng, Ma, Liping, Gao, Mei, Hou, Yinglong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038774/ https://www.ncbi.nlm.nih.gov/pubmed/32109992 http://dx.doi.org/10.2147/DDDT.S242167 |
Ejemplares similares
-
CYP2C19(⁎)2 Polymorphism in Chilean Patients with In-Stent Restenosis Development and Controls
por: Ruedlinger, Jenny, et al.
Publicado: (2017) -
Association between CYP2C19 and ABCB1 polymorphisms and clopidogrel resistance in clopidogrel-treated Chinese patients
por: Zhuo, Zhong-ling, et al.
Publicado: (2018) -
Comment on “Association between CYP2C19 and ABCB1 polymorphisms and clopidogrel resistance in clopidogrel-treated Chinese patients”
por: Wang, Bin, et al.
Publicado: (2018) -
Association with CYP2C19 polymorphisms and Clopidogrel in treatment of elderly stroke patients
por: Li, Changqing, et al.
Publicado: (2021) -
Analysis of the incidence and influencing factors associated with binary restenosis of target lesions after drug-coated balloon angioplasty for patients with in-stent restenosis
por: Xue, Weihao, et al.
Publicado: (2022)